A constructivist grounded theory study on decision‐making for treatment choice among Black African and Black Caribbean prostate cancer survivors. (10th October 2021)

• Record Type: Journal Article
• Authors: Bamidele, Olufikayo O.; McCaughan, Eilis
• Is Part Of: European journal of cancer care. Volume 31:Number 1(2022)
• Page Start: n/a
• Page End: n/a
• Publication Date: 2021-10-10
• Subjects: black African -- black Caribbean -- grounded theory -- Prostate cancer -- qualitative research -- treatment decision‐making; Cancer -- Nursing -- Periodicals; 616.994
• DOI: 10.1111/ecc.13516
• Languages: English
• ISSNs: 0961-5423

Abstract

Abstract: Objective: Despite Black African (BA) and Black Caribbean (BC) men having a disproportionately high risk (1 in 4) of developing prostate cancer (CaP), there is limited understanding of their decision‐making for treatment choice. This study explored decision‐making for treatment choice among BA/BC men treated for CaP. Methods: Using constructivist grounded theory, face‐to‐face, Skype and telephone interviews were conducted with 25 Black men (8 BA, 17 BC) recruited in England between October 2016 and March 2018. Data were analysed using constant comparison until saturation was achieved. Results: Data analysis yielded three broad categories: 'coming to terms with the prostate cancer diagnosis', 'getting empowerment through information‐seeking' and 'choosing a treatment option'. Priority for survival substantially motivated BA/BC men to take up radical treatment for their CaP. However, decision‐making for a particular treatment option was a more complex process which was shaped by an intersection between biological, behavioural, medical, personal and cultural factors. Conclusions: Healthcare providers need to consider the complexity of decision‐making process for CaP treatment among BA/BC men and tailor cancer care services to reflect cultural sensitivity and person‐centredness. This could potentially minimise treatment decision regrets and improve men's psychological wellbeing along the CaP survivorship pathway.